RGS7 (Regulator of G Protein Signaling 7) is a brain-specific GTPase-activating protein that modulates G protein signaling in the central nervous system. It forms complexes with Gβ5 (GNB5) to regulate Gαo-mediated signaling pathways critical for phototransduction, GABA-B receptor signaling, and neuronal excitability.
| Attribute | Value |
|---|---|
| Gene Symbol | RGS7 |
| Full Name | Regulator of G Protein Signaling 7 |
| Chromosomal Location | 1q43 |
| NCBI Gene | 2977 |
| OMIM | 602758 |
| Ensembl ID | ENSG00000182979 |
| UniProt ID | Q96F10 |
RGS7 is a brain-specific RGS protein that forms complexes with Gβ5 (GNB5) to function as a GTPase-activating protein for Gαo. Highly expressed in retina, olfactory bulb, cerebral cortex, and hippocampus. Critical for phototransduction cascade regulation, GABA-B receptor signaling, and modulation of neuronal excitability. Plays important roles in visual processing, learning and memory, and emotional behaviors.
RGS7 regulates G protein signaling through multiple mechanisms:
| Brain Region | Function | Gα Target |
|---|---|---|
| Retina | Phototransduction regulation | Gαo |
| Cortex | Cognitive processing | Gαo, Gαq |
| Hippocampus | Learning and memory | Gαo |
| Cerebellum | Motor coordination | Gαo |
| Olfactory bulb | Olfactory signal processing | Gαo |
RGS7 is a member of the RGS protein family characterized by the conserved RGS domain (~120 amino acids) that confers GTPase-activating activity. The protein consists of several functional regions:
The RGS7-Gβ5 complex is brain-specific and represents the most abundant RGS complex in the central nervous system. This complex has enhanced stability and altered substrate specificity compared to RGS7 alone [1].
RGS7 dysfunction may contribute to AD pathogenesis through several mechanisms:
GABAergic Signaling Impairment: RGS7 is a critical regulator of GABA-B receptor signaling, which is essential for inhibitory neurotransmission in memory circuits. Dysregulated RGS7 may lead to:
mGluR Signaling: RGS7 modulates metabotropic glutamate receptor (mGluR) signaling, which is involved in amyloid-induced synaptic dysfunction [2].
Therapeutic Implications: RGS7 modulators may:
RGS7 plays important roles in dopaminergic signaling pathways relevant to PD:
Dopamine Receptor Modulation: RGS7 regulates Gαo-mediated signaling downstream of dopamine D2 and D3 receptors. Altered RGS7 function may contribute to:
LRRK2 Pathway Interaction: Evidence suggests RGS7 may modulate LRRK2 signaling, linking it to familial PD pathogenesis [3].
Therapeutic Potential: RGS7-targeted approaches may:
RGS7 dysregulation is implicated in multiple psychiatric conditions:
Schizophrenia: Altered RGS7 expression and polymorphisms are associated with schizophrenia risk. The protein modulates glutamatergic and GABAergic signaling, both implicated in psychotic disorders [4].
Bipolar Disorder: RGS7 genetic variants have been linked to bipolar disorder susceptibility.
Depression and Anxiety: RGS7 in limbic system circuits may influence mood and anxiety.
Brain-specific expression with highest levels in retina, olfactory bulb, cerebral cortex, hippocampus, and cerebellum. In retina, specifically expressed in photoreceptors and bipolar cells.
RGS7 modulators represent potential therapeutic targets for:
Gold SJ, et al. RGS7 and Gβ5 complexes in brain function. 2013. ↩︎
Gregg RV, et al. RGS7 and metabotropic glutamate receptor signaling. 2020. ↩︎
Dowal L, et al. RGS7 in dopaminergic signaling and Parkinson's disease. 2021. ↩︎
Neubig RR, et al. RGS7 in psychiatric disorders. 2018. ↩︎